Guduchi (Giloy) for Anti-Inflammatory

Research suggests that Tinospora cordifolia (Guduchi/Giloy) possesses anti-inflammatory properties supported by a modest body of preclinical and review-level evidence, with multiple review articles from 2017 through 2025 consistently identifying bioactive compounds — including alkaloids, flavonoids, and diterpenoid lactones — that demonstrate anti-inflammatory activity in laboratory settings, and a 2024 in vitro and in silico study providing more direct mechanistic evidence showing suppression of pro-inflammatory cytokines. Studies indicate the available evidence is largely preclinical and review-based, with no randomized controlled trials or clinical studies specifically addressing anti-inflammatory outcomes included in this body of literature, which limits the conclusions that can be drawn about effects in humans. A notable safety concern emerges from a 2023 review examining reported cases of liver injury associated with Guduchi products, though the authors concluded that adulteration or substitution with the related hepatotoxic species Tinospora crispa, rather than authentic Tinospora cordifolia itself, was the more likely explanation — underscoring that product quality and botanical authenticity are important considerations when evaluating both the safety and efficacy evidence for this herb.